TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

Compare

133.30

-5.99 (-4.30%)

At close: Feb 11, 2026, 4:00 PM EST

133.80

+0.50 (0.38%)

After-hours: Feb 11, 2026, 5:19 PM EST

TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	566.35	441.54	241.62	93.46	30.26	25.64
Revenue Growth (YoY)	41.20%	82.74%	158.53%	208.83%	18.03%	8.62%
Cost of Revenue	224.95	179.46	87.53	28.19	9.1	9
Gross Profit	341.41	262.08	154.09	65.27	21.16	16.64
Selling, General & Admin	180.63	168.62	117.55	69.9	38.28	24.19
Research & Development	64.82	55.97	36.06	26.81	22.3	18.83
Operating Expenses	245.45	224.59	153.61	96.71	60.59	43.02
Operating Income	95.95	37.5	0.49	-31.44	-39.43	-26.38
Interest Expense	-14	-14.41	-10.79	-3.73	-3.87	-3.99
Interest & Investment Income	11	13.4	12.5	-	-	-
Currency Exchange Gain (Loss)	1.4	0.7	0.3	-	-1	1
Other Non Operating Income (Expenses)	-1.48	-1.41	0.05	-0.43	0.12	0.65
EBT Excluding Unusual Items	92.88	35.78	2.54	-35.59	-44.18	-28.72
Merger & Restructuring Charges	-	-	-2	-	-	-
Other Unusual Items	-	-	-	-0.58	-	-
Pretax Income	92.88	35.78	-26.67	-36.17	-44.18	-28.72
Income Tax Expense	1.11	0.32	-1.64	0.07	0.04	0.03
Net Income	91.77	35.46	-25.03	-36.23	-44.22	-28.75
Net Income to Common	91.77	35.46	-25.03	-36.23	-44.22	-28.75
Shares Outstanding (Basic)	34	33	33	30	28	25
Shares Outstanding (Diluted)	39	35	33	30	28	25
Shares Change (YoY)	13.12%	8.30%	10.02%	7.02%	11.80%	73.91%
EPS (Basic)	2.71	1.07	-0.77	-1.23	-1.60	-1.16
EPS (Diluted)	2.54	1.01	-0.77	-1.23	-1.60	-1.16
Free Cash Flow	120.65	-80.94	-164.88	-57.72	-32.38	-30.72
Free Cash Flow Per Share	3.08	-2.30	-5.07	-1.95	-1.17	-1.24
Gross Margin	60.28%	59.36%	63.77%	69.84%	69.92%	64.88%
Operating Margin	16.94%	8.49%	0.20%	-33.64%	-130.29%	-102.91%
Profit Margin	16.20%	8.03%	-10.36%	-38.77%	-146.11%	-112.13%
Free Cash Flow Margin	21.30%	-18.33%	-68.24%	-61.76%	-107.01%	-119.82%
EBITDA	120.55	57.25	8.66	-27.96	-37.61	-24.81
EBITDA Margin	21.29%	12.97%	3.58%	-29.92%	-124.28%	-96.75%
D&A For EBITDA	24.6	19.76	8.18	3.48	1.82	1.58
EBIT	95.95	37.5	0.49	-31.44	-39.43	-26.38
EBIT Margin	16.94%	8.49%	0.20%	-33.64%	-130.29%	-102.91%
Effective Tax Rate	1.20%	0.88%	-	-	-	-
Revenue as Reported	566.35	441.54	241.62	93.46	30.26	25.64

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q